HI
COLL icon

Horizon Investments’s Collegium Pharmaceutical COLL Stock Holding History

Horizon Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,980
Closed -$628K – 1423
2026
Q1 		$628K Buy
18,980
+6,050
+47% +$256K 0.01% 851
2025
Q4 		$599K Sell
12,930
-1,698
-12% -$71K 0.01% 817
2025
Q3 		$512K Buy
+14,628
New +$508K 0.01% 835

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Horizon Investments's COLL Position: Q2 2026 in Review

Horizon Investments sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 18,980 shares — an estimated $628K sold.

Horizon Investments first reported a position in COLL in Q3 2025 and held it in 3 quarters. The position peaked at $628K in Q1 2026. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Horizon Investments reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Horizon Investments sold 18,980 Collegium Pharmaceutical shares in Q2 2026, an estimated $628K.
  • Horizon Investments first reported a position in Collegium Pharmaceutical in Q3 2025 and held it in 3 quarters.
  • Horizon Investments's Collegium Pharmaceutical position peaked at $628K in Q1 2026.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.